Sahebarao P. Mahadik - Publications

Affiliations: 
Medical College of Georgia, Augusta, GA, United States 
Area:
Neurochemistry of Mental Illness

113 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2011 Kale A, Joshi SR, Mahadik SP. Novel mechanism for oxidative stress in neurodevelopmental pathophysiology and course of schizophrenia Molecular Aspects of Neurodegeneration and Neuroprotection. 102-120. DOI: 10.2174/978160805092511101010102  0.6
2010 Jindal RD, Pillai AK, Mahadik SP, Eklund K, Montrose DM, Keshavan MS. Decreased BDNF in patients with antipsychotic naïve first episode schizophrenia. Schizophrenia Research. 119: 47-51. PMID 20096541 DOI: 10.1016/j.schres.2009.12.035  0.6
2010 Pillai A, Kale A, Joshi S, Naphade N, Raju MS, Nasrallah H, Mahadik SP. Decreased BDNF levels in CSF of drug-naive first-episode psychotic subjects: correlation with plasma BDNF and psychopathology. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 13: 535-9. PMID 19941699 DOI: 10.1017/S1461145709991015  0.6
2009 Kale A, Joshi S, Pillai A, Naphade N, Raju M, Nasrallah H, Mahadik SP. Reduced cerebrospinal fluid and plasma nerve growth factor in drug-naïve psychotic patients. Schizophrenia Research. 115: 209-14. PMID 19713082 DOI: 10.1016/J.Schres.2009.07.022  0.6
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection. Pharmacological Reviews. 60: 358-403. PMID 18922967 DOI: 10.1124/Pr.107.00107  0.6
2008 Terry AV, Warner SE, Vandenhuerk L, Pillai A, Mahadik SP, Zhang G, Bartlett MG. Negative effects of chronic oral chlorpromazine and olanzapine treatment on the performance of tasks designed to assess spatial learning and working memory in rats. Neuroscience. 156: 1005-16. PMID 18801413 DOI: 10.1016/J.Neuroscience.2008.08.030  0.6
2008 Pillai A, Veeranan-Karmegam R, Dhandapani KM, Mahadik SP. Cystamine prevents haloperidol-induced decrease of BDNF/TrkB signaling in mouse frontal cortex. Journal of Neurochemistry. 107: 941-51. PMID 18786174 DOI: 10.1111/J.1471-4159.2008.05665.X  0.6
2008 Pillai A, Mahadik SP. Increased truncated TrkB receptor expression and decreased BDNF/TrkB signaling in the frontal cortex of reeler mouse model of schizophrenia. Schizophrenia Research. 100: 325-33. PMID 18187310 DOI: 10.1016/J.Schres.2007.11.030  0.6
2008 Kale A, Joshi S, Naphade N, Sapkale S, Raju MS, Pillai A, Nasrallah H, Mahadik SP. Opposite changes in predominantly docosahexaenoic acid (DHA) in cerebrospinal fluid and red blood cells from never-medicated first-episode psychotic patients. Schizophrenia Research. 98: 295-301. PMID 17997280 DOI: 10.1016/J.Schres.2007.09.036  0.6
2008 Pillai A, Dhandapani KM, Pillai BA, Terry AV, Mahadik SP. Erythropoietin prevents haloperidol treatment-induced neuronal apoptosis through regulation of BDNF. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 33: 1942-51. PMID 17805306 DOI: 10.1038/Sj.Npp.1301566  0.6
2008 Lieberman JA, Bymaster FP, Meltzer HY, Deutch AY, Duncan GE, Marx CE, Aprille JR, Dwyer DS, Li XM, Mahadik SP, Duman RS, Porter JH, Modica-Napolitano JS, Newton SS, Csernansky JG. Antipsychotic drugs: Comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection (Pharmacological Reviews (2002) 60, (358-403)) Pharmacological Reviews. 60: 582.  0.6
2007 Terry AV, Gearhart DA, Warner S, Hohnadel EJ, Middlemore ML, Zhang G, Bartlett MG, Mahadik SP. Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats. Neuroscience. 150: 413-24. PMID 17942237 DOI: 10.1016/j.neuroscience.2007.09.014  0.6
2007 Rao SS, Kale AA, Joshi SR, Mahadik SP. Sensitivity of fetus and pups to excess levels of maternal intakes of alpha linolenic acid at marginal protein levels in Wistar rats. Reproductive Toxicology (Elmsford, N.Y.). 24: 333-42. PMID 17825521 DOI: 10.1016/j.reprotox.2007.07.007  0.6
2007 Buckley PF, Mahadik S, Pillai A, Terry A. Neurotrophins and schizophrenia Schizophrenia Research. 94: 1-11. PMID 17524622 DOI: 10.1016/J.Schres.2007.01.025  0.36
2007 Terry AV, Gearhart DA, Warner SE, Zhang G, Bartlett MG, Middlemore ML, Beck WD, Mahadik SP, Waller JL. Oral haloperidol or risperidone treatment in rats: temporal effects on nerve growth factor receptors, cholinergic neurons, and memory performance. Neuroscience. 146: 1316-32. PMID 17434684 DOI: 10.1016/j.neuroscience.2007.03.003  0.6
2007 Buckley PF, Pillai A, Evans D, Stirewalt E, Mahadik S. Brain derived neurotropic factor in first-episode psychosis Schizophrenia Research. 91: 1-5. PMID 17306505 DOI: 10.1016/J.Schres.2006.12.026  0.36
2007 Terry AV, Mahadik SP. Time-dependent cognitive deficits associated with first and second generation antipsychotics: cholinergic dysregulation as a potential mechanism. The Journal of Pharmacology and Experimental Therapeutics. 320: 961-8. PMID 16966470 DOI: 10.1124/jpet.106.106047  0.6
2007 Pillai A, Parikh V, Terry AV, Mahadik SP. Long-term antipsychotic treatments and crossover studies in rats: differential effects of typical and atypical agents on the expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research. 41: 372-86. PMID 16564057 DOI: 10.1016/j.jpsychires.2006.01.011  0.6
2006 Pillai A, Mahadik SP. Differential effects of haloperidol and olanzapine on the expression of erythropoietin and its receptor in rat hippocampus and striatum. Journal of Neurochemistry. 98: 1411-22. PMID 16923156 DOI: 10.1111/j.1471-4159.2006.04057.x  0.6
2006 Pillai A, Mahadik SP. Differential effects of haloperidol and olanzapine on levels of vascular endothelial growth factor and angiogenesis in rat hippocampus. Schizophrenia Research. 87: 48-59. PMID 16859894 DOI: 10.1016/j.schres.2006.06.017  0.6
2006 Mahadik SP, Pillai A, Joshi S, Foster A. Prevention of oxidative stress-mediated neuropathology and improved clinical outcome by adjunctive use of a combination of antioxidants and omega-3 fatty acids in schizophrenia. International Review of Psychiatry (Abingdon, England). 18: 119-31. PMID 16777666 DOI: 10.1080/09540260600581993  0.6
2006 Terry AV, Parikh V, Gearhart DA, Pillai A, Hohnadel E, Warner S, Nasrallah HA, Mahadik SP. Time-dependent effects of haloperidol and ziprasidone on nerve growth factor, cholinergic neurons, and spatial learning in rats. The Journal of Pharmacology and Experimental Therapeutics. 318: 709-24. PMID 16702442 DOI: 10.1124/jpet.105.099218  0.6
2006 Terry AV, Gearhart DA, Mahadik SP, Warsi S, Waller JL. Chronic treatment with first or second generation antipsychotics in rodents: effects on high affinity nicotinic and muscarinic acetylcholine receptors in the brain. Neuroscience. 140: 1277-87. PMID 16626873 DOI: 10.1016/j.neuroscience.2006.03.011  0.6
2006 Pillai A, Terry AV, Mahadik SP. Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus. Schizophrenia Research. 82: 95-106. PMID 16442781 DOI: 10.1016/J.Schres.2005.11.021  0.6
2006 Joshi K, Lad S, Kale M, Patwardhan B, Mahadik SP, Patni B, Chaudhary A, Bhave S, Pandit A. Supplementation with flax oil and vitamin C improves the outcome of Attention Deficit Hyperactivity Disorder (ADHD). Prostaglandins, Leukotrienes, and Essential Fatty Acids. 74: 17-21. PMID 16314082 DOI: 10.1016/j.plefa.2005.10.001  0.6
2005 Terry AV, Gearhart DA, Mahadik SP, Warsi S, Davis LW, Waller JL. Chronic exposure to typical or atypical antipsychotics in rodents: temporal effects on central alpha7 nicotinic acetylcholine receptors. Neuroscience. 136: 519-29. PMID 16216423 DOI: 10.1016/j.neuroscience.2005.08.006  0.6
2005 Skinner AO, Mahadik SP, Garver DL. Thiobarbituric acid reactive substances in the cerebrospinal fluid in schizophrenia. Schizophrenia Research. 76: 83-7. PMID 15927801 DOI: 10.1016/j.schres.2004.10.010  0.6
2004 Parikh V, Khan MM, Terry A, Mahadik SP. Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats. Journal of Psychiatric Research. 38: 521-9. PMID 15380403 DOI: 10.1016/j.jpsychires.2004.03.008  0.6
2004 Parikh V, Khan MM, Mahadik SP. Olanzapine counteracts reduction of brain-derived neurotrophic factor and TrkB receptors in rat hippocampus produced by haloperidol. Neuroscience Letters. 356: 135-9. PMID 14746882 DOI: 10.1016/j.neulet.2003.10.079  0.6
2004 Parikh V, Terry AV, Khan MM, Mahadik SP. Modulation of nerve growth factor and choline acetyltransferase expression in rat hippocampus after chronic exposure to haloperidol, risperidone, and olanzapine. Psychopharmacology. 172: 365-74. PMID 14647958 DOI: 10.1007/s00213-003-1669-6  0.6
2003 Ranjekar PK, Hinge A, Hegde MV, Ghate M, Kale A, Sitasawad S, Wagh UV, Debsikdar VB, Mahadik SP. Decreased antioxidant enzymes and membrane essential polyunsaturated fatty acids in schizophrenic and bipolar mood disorder patients. Psychiatry Research. 121: 109-22. PMID 14656446 DOI: 10.1016/S0165-1781(03)00220-8  0.6
2003 Evans DR, Parikh VV, Khan MM, Coussons C, Buckley PF, Mahadik SP. Red blood cell membrane essential fatty acid metabolism in early psychotic patients following antipsychotic drug treatment. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 69: 393-9. PMID 14623492 DOI: 10.1016/j.plefa.2003.08.010  0.6
2003 Khan MM, Parikh VV, Mahadik SP. Antipsychotic drugs differentially modulate apolipoprotein D in rat brain. Journal of Neurochemistry. 86: 1089-100. PMID 12911617 DOI: 10.1046/J.1471-4159.2003.01866.X  0.6
2003 Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of omega-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Research. 62: 195-204. PMID 12837515 DOI: 10.1016/S0920-9964(02)00284-0  0.6
2003 Mahadik SP, Evans DR. Is schizophrenia a metabolic brain disorder? Membrane phospholipid dysregulation and its therapeutic implications. The Psychiatric Clinics of North America. 26: 85-102. PMID 12683261 DOI: 10.1016/S0193-953X(02)00033-3  0.6
2003 Parikh V, Evans DR, Khan MM, Mahadik SP. Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome. Schizophrenia Research. 60: 117-23. PMID 12591576 DOI: 10.1016/S0920-9964(02)00434-6  0.6
2003 Terry AV, Hill WD, Parikh V, Waller JL, Evans DR, Mahadik SP. Differential effects of haloperidol, risperidone, and clozapine exposure on cholinergic markers and spatial learning performance in rats. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 28: 300-9. PMID 12589383 DOI: 10.1038/sj.npp.1300039  0.6
2003 Arvindakshan M, Sitasawad S, Debsikdar V, Ghate M, Evans D, Horrobin DF, Bennett C, Ranjekar PK, Mahadik SP. Essential polyunsaturated fatty acid and lipid peroxide levels in never-medicated and medicated schizophrenia patients. Biological Psychiatry. 53: 56-64. PMID 12513945 DOI: 10.1016/S0006-3223(02)01443-9  0.6
2003 Parikh V, Khan MM, Mahadik SP. Differential effects of antipsychotics on expression of antioxidant enzymes and membrane lipid peroxidation in rat brain. Journal of Psychiatric Research. 37: 43-51. PMID 12482469 DOI: 10.1016/S0022-3956(02)00048-1  0.6
2002 Terry AV, Hill WD, Parikh V, Evans DR, Waller JL, Mahadik SP. Differential effects of chronic haloperidol and olanzapine exposure on brain cholinergic markers and spatial learning in rats. Psychopharmacology. 164: 360-8. PMID 12457265 DOI: 10.1007/s00213-002-1230-z  0.6
2002 Mahadik SP, Khan MM, Evans DR, Parikh VV. Elevated plasma level of apolipoprotein D in schizophrenia and its treatment and outcome. Schizophrenia Research. 58: 55-62. PMID 12363390 DOI: 10.1016/S0920-9964(01)00378-4  0.6
2002 Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Research. 58: 1-10. PMID 12363384 DOI: 10.1016/S0920-9964(01)00334-6  0.6
2002 Wakade CG, Mahadik SP, Waller JL, Chiu FC. Atypical neuroleptics stimulate neurogenesis in adult rat brain. Journal of Neuroscience Research. 69: 72-9. PMID 12111817 DOI: 10.1002/jnr.10281  0.6
2001 Mahadik SP, Evans D, Lal H. Oxidative stress and role of antioxidant and omega-3 essential fatty acid supplementation in schizophrenia. Progress in Neuro-Psychopharmacology & Biological Psychiatry. 25: 463-93. PMID 11370992 DOI: 10.1016/S0278-5846(00)00181-0  0.6
1998 Mahadik SP, Mukherjee S, Scheffer R, Correnti EE, Mahadik JS. Elevated plasma lipid peroxides at the onset of nonaffective psychosis. Biological Psychiatry. 43: 674-9. PMID 9583001 DOI: 10.1016/S0006-3223(97)00282-5  0.6
1997 Mahadik SP, Evans DR. Essential fatty acids in the treatment of schizophrenia Drugs of Today. 33: 5-17.  0.6
1996 Mukerjee S, Mahadik SP, Scheffer R, Correnti EE, Kelkar H. Impaired antioxidant defense at the onset of psychosis. Schizophrenia Research. 19: 19-26. PMID 9147492 DOI: 10.1016/0920-9964(95)00048-8  0.6
1996 Mahadik SP, Mukherjee S. Free radical pathology and antioxidant defense in schizophrenia: a review. Schizophrenia Research. 19: 1-17. PMID 9147491 DOI: 10.1016/0920-9964(95)00049-6  0.6
1996 Mahadik SP, Mukherjee S. Cultured skin fibroblasts as a cell model for investigating schizophrenia. Journal of Psychiatric Research. 30: 421-39. PMID 9023786 DOI: 10.1016/S0022-3956(96)00025-8  0.6
1996 Bates PR, Hawkins A, Mahadik SP, McGrath JJ. Heat stress lipids and schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 55: 101-7. PMID 8888131  0.6
1996 Mahadik SP, Shendarkar NS, Scheffer RE, Mukherjee S, Correnti EE. Utilization of precursor essential fatty acids in culture by skin fibroblasts from schizophrenic patients and normal controls. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 55: 65-70. PMID 8888125  0.6
1996 Mahadik SP, Scheffer RE. Oxidative injury and potential use of antioxidants in schizophrenia. Prostaglandins, Leukotrienes, and Essential Fatty Acids. 55: 45-54. PMID 8888122  0.6
1996 Mahadik SP, Mukherjee S, Horrobin DF, Jenkins K, Correnti EE, Scheffer RE. Plasma membrane phospholipid fatty acid composition of cultured skin fibroblasts from schizophrenic patients: comparison with bipolar patients and normal subjects. Psychiatry Research. 63: 133-42. PMID 8878309 DOI: 10.1016/0165-1781(96)02899-5  0.6
1996 Mahadik SP, Gowda S. Antioxidants in the treatment of schizophrenia Drugs of Today. 32: 553-565.  0.6
1995 Mahadik SP, Mukherjee S. Monosialoganglioside cotreatment prevents haloperidol treatment-associated loss of cholinergic enzymes in rat brain. Biological Psychiatry. 38: 246-54. PMID 8547447 DOI: 10.1016/0006-3223(94)00304-L  0.6
1994 Mukherjee S, Mahadik SP, Korenovsky A, Laev H, Schnur DB, Reddy R. Serum antibodies to nicotinic acetylcholine receptors in schizophrenic patients. Schizophrenia Research. 12: 131-6. PMID 8043523 DOI: 10.1016/0920-9964(94)90070-1  0.6
1994 Mahadik SP, Mukherjee S, Wakade CG, Laev H, Reddy RR, Schnur DB. Decreased adhesiveness and altered cellular distribution of fibronectin in fibroblasts from schizophrenic patients. Psychiatry Research. 53: 87-97. PMID 7991734 DOI: 10.1016/0165-1781(94)90097-3  0.6
1994 Mahadik SP, Mukherjee S, Correnti EE, Kelkar HS, Wakade CG, Costa RM, Scheffer R. Plasma membrane phospholipid and cholesterol distribution of skin fibroblasts from drug-naive patients at the onset of psychosis. Schizophrenia Research. 13: 239-47. PMID 7841137 DOI: 10.1016/0920-9964(94)90048-5  0.6
1994 Mukherjee S, Mahadik SP, Schnur DB, Laev H, Reddy R. Abnormal growth of cultured skin fibroblasts associated with poor premorbid history in schizophrenic patients. Schizophrenia Research. 13: 233-7. PMID 7841136 DOI: 10.1016/0920-9964(94)90047-7  0.6
1994 Mukherjee S, Mahadik SP. A new paradigm for schizophrenia? Schizophrenia Research. 13: 191-4. PMID 7841131 DOI: 10.1016/0920-9964(94)90042-6  0.6
1993 Hungund BL, Mahadik SP. Role of gangliosides in behavioral and biochemical actions of alcohol: cell membrane structure and function. Alcoholism, Clinical and Experimental Research. 17: 329-39. PMID 8488975  0.6
1993 Mahadik SP, Makar TK, Murthy JN, Ortiz A, Wakade CG, Karpiak SE. Temporal changes in superoxide dismutase, glutathione peroxidase, and catalase levels in primary and peri-ischemic tissue. Monosialoganglioside (GM1) treatment effects. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 18: 1-14. PMID 8466585 DOI: 10.1007/BF03160018  0.6
1993 Mahadik SP, Hungund BL, Gokhale VS, Ortiz A, Makar TK, Karpiak SE. Monosialoganglioside (GM1) restores membrane fatty acid levels in ischemic tissue after cortical focal ischemia in rat. Neurochemistry International. 23: 163-72. PMID 8369740 DOI: 10.1016/0197-0186(93)90094-L  0.6
1993 Laev H, Mahadik SP, Bonheur JL, Hernandez N, Karpiak SE. GM1 ganglioside reduces glutamate toxicity to cortical cells. Lowered LDH release and preserved membrane integrity. Molecular and Chemical Neuropathology / Sponsored by the International Society For Neurochemistry and the World Federation of Neurology and Research Groups On Neurochemistry and Cerebrospinal Fluid. 20: 229-43. PMID 7909662 DOI: 10.1007/BF03160076  0.6
1992 Keshavan MS, Mahadik SP, Reynolds CF, Mukerjee S, Korenovsky A, Houck P, Jarrett DB. Plasma cholinesterase isozymes and REM latency in schizophrenia. Psychiatry Research. 43: 23-9. PMID 1438614 DOI: 10.1016/0165-1781(92)90138-S  0.6
1992 Stadlin A, Tsang D, MacDonall JS, Mahadik SP, Karpiak SE. An in vitro study on increased neuronal and astrocytic vulnerability to neurotoxic injury after in utero cocaine exposure: the reversal effects of GM1 treatment. Progress in Brain Research. 94: 339-50. PMID 1363146 DOI: 10.1016/S0079-6123(08)61763-X  0.6
1992 Mahadik SP, Bharucha VA, Stadlin A, Ortiz A, Karpiak SE. Loss and recovery of activities of alpha+ and alpha isozymes of (Na(+) + K+)-ATPase in cortical focal ischemia: GM1 ganglioside protects plasma membrane structure and function. Journal of Neuroscience Research. 32: 209-20. PMID 1328661 DOI: 10.1002/Jnr.490320210  0.6
1992 Mahadik SP, Wakade CG. Cortical focal stroke model to evaluate neuroprotective action of drugs Drug Development Research. 27: 307-327. DOI: 10.1002/ddr.430270402  0.6
1991 Bharucha VA, Wakade CG, Mahadik SP, Karpiak SE. GM1 ganglioside treatment reduces functional deficits associated with cortical focal ischemia. Experimental Neurology. 114: 136-9. PMID 1915729 DOI: 10.1016/0014-4886(91)90091-P  0.6
1991 Mahadik SP, Mukherjee S, Laev H, Reddy R, Schnur DB. Abnormal growth of skin fibroblasts from schizophrenic patients. Psychiatry Research. 37: 309-20. PMID 1891511 DOI: 10.1016/0165-1781(91)90066-X  0.6
1991 Karpiak SE, Wakade CG, Tagliavia A, Mahadik SP. Temporal changes in edema, Na+, K+, and Ca++ in focal cortical stroke: GM1 ganglioside reduces ischemic injury. Journal of Neuroscience Research. 30: 512-20. PMID 1800772 DOI: 10.1002/jnr.490300308  0.6
1991 Hungund BL, Gokhale VS, Cooper TB, Mahadik SP. Prenatal ganglioside GM1 treatment protects ethanol-induced sleep time in rats exposed to ethanol in utero during gestation days 7 and 8 Drug Development Research. 24: 261-267.  0.6
1990 Korenovsky A, Laev H, Mukherjee S, Mahadik SP. Quantitative analyses of plasma cholinesterase isozymes in haloperidol-treated rats. Biological Psychiatry. 27: 871-83. PMID 2331495 DOI: 10.1016/0006-3223(90)90468-H  0.6
1990 Karpiak SE, Mahadik SP, Wakade CG. Ganglioside reduction of ischemic injury. Critical Reviews in Neurobiology. 5: 221-37. PMID 2204483  0.6
1990 Karpiak SE, Mahadik SP. Enhanced cortical maturation: gangliosides in CNS plasticity. Progress in Brain Research. 85: 299-308; discussion . PMID 2094899  0.6
1990 Hungund BL, Reddy MV, Bharucha VA, Mahadik SP. Monosialogangliosides (GM1 and AGF2) reduce acute ethanol intoxication: Sleep time, mortality, and cerebral cortical Na+,K+-ATPase Drug Development Research. 19: 443-451. DOI: 10.1002/ddr.430190409  0.6
1989 Laev H, Mahadik SP. Topography of monosialoganglioside (GM1) in rat brain using monoclonal antibodies. Neuroscience Letters. 102: 7-14. PMID 2779846 DOI: 10.1016/0304-3940(89)90299-1  0.6
1989 Mahadik SP, Hawver DB, Hungund BL, Li YS, Karpiak SE. GM1 ganglioside treatment after global ischemia protects changes in membrane fatty acids and properties of Na+, K+-ATPase and Mg2+-ATPase. Journal of Neuroscience Research. 24: 402-12. PMID 2531806 DOI: 10.1002/jnr.490240310  0.6
1988 Spoerri PE, Rapport MM, Mahadik SP, Roisen FJ. Inhibition of conditioned media-mediated neuritogenesis of sensory ganglia by monoclonal antibodies to GM1 ganglioside. Brain Research. 469: 71-7. PMID 3401809 DOI: 10.1016/0165-3806(88)90170-8  0.6
1988 Mahadik SP, Laev H, Korenovsky A, Karpiak SE. Haloperidol alters rat CNS cholinergic system: enzymatic and morphological analyses. Biological Psychiatry. 24: 199-217. PMID 3291956 DOI: 10.1016/0006-3223(88)90275-2  0.6
1988 Mahadik SP, Vilim F, Korenovsky A, Karpiak SE. GM1 ganglioside protects nucleus basalis from excitotoxin damage: reduced cortical cholinergic losses and animal mortality. Journal of Neuroscience Research. 20: 479-83. PMID 3184210 DOI: 10.1002/jnr.490200411  0.6
1988 Mahadik SP, Karpiak SK. Gangliosides in treatment of neural injury and disease Drug Development Research. 15: 337-360. DOI: 10.1002/Ddr.430150402  0.6
1987 Karpiak SE, Mahadik SP. Selective uptake by Purkinje neurons of antibodies to S-100 protein. Experimental Neurology. 98: 453-7. PMID 3666088 DOI: 10.1016/0014-4886(87)90254-8  0.6
1987 Fass B, Ramirez JJ, Stein DG, Mahadik SP, Karpiak SE. Ganglioside-induced alterations in hippocampal cholinergic enzymes and Na,K-ATPase after fimbria-fornix transection. Journal of Neuroscience Research. 17: 45-50. PMID 3033257 DOI: 10.1002/Jnr.490170107  0.6
1987 Karpiak SE, Li YS, Mahadik SP. Gangliosides (GM1 and AGF2) reduce mortality due to ischemia: protection of membrane function. Stroke; a Journal of Cerebral Circulation. 18: 184-7. PMID 3027926  0.6
1987 Karpiak SE, Li YS, Mahadik SP. Ganglioside treatment: reduction of CNS injury and facilitation of functional recovery. Brain Injury. 1: 161-70. PMID 2457399 DOI: 10.3109/02699058709034454  0.6
1986 Karpiak SE, Li YS, Mahadik SP. Gangliosides reduce mortality due to global ischemia: membrane protection. Clinical Neuropharmacology. 9: 338-40. PMID 3032429  0.6
1986 Li YS, Mahadik SP, Rapport MM, Karpiak SE. Acute effects of GM1 ganglioside: reduction in both behavioral asymmetry and loss of Na+, K+-ATPase after nigrostriatal transection. Brain Research. 377: 292-7. PMID 3015350 DOI: 10.1016/0006-8993(86)90871-1  0.6
1986 Mahadik SP, Karpiak SE. GM1 ganglioside enhances neonatal cortical development. Neurotoxicology. 7: 161-8. PMID 2431363  0.6
1986 Mahadik SP, Laev H, Rapport MM. Preparation and specificity of 11 monoclonal antibodies to GM1 ganglioside. Journal of Neurochemistry. 47: 1172-5. PMID 2427655  0.6
1984 Karpiak SE, Mahadik SP. Reduction of cerebral edema with GM1 ganglioside. Journal of Neuroscience Research. 12: 485-92. PMID 6094838 DOI: 10.1002/jnr.490120231  0.6
1983 Karpiak SE, Vilim F, Mahadik SP. Gangliosides accelerate rat neonatal learning and levels of cortical acetylcholinesterases. Developmental Neuroscience. 6: 127-35. PMID 6678760  0.6
1982 Mahadik SP, Korenovsky A, Ciccarone V, Laev H. Synaptic membrane antigens in developing rat brain cerebral cortex and cerebellum. Journal of Neurochemistry. 39: 1340-7. PMID 7119801  0.6
1981 Karpiak SE, Mahadik SP, Graf L, Rapport MM. An immunological model of epilepsy: seizures induced by antibodies to GM1 ganglioside. Epilepsia. 22: 189-96. PMID 7472306  0.6
1981 Hungund BL, Mahadik SP. Topographic studies of gangliosides of intact synaptosomes from rat brain cortex. Neurochemical Research. 6: 183-91. PMID 7242778 DOI: 10.1007/BF00964835  0.6
1981 Mahadik SP, Korenovsky A, Ciccarone V, Rapport MM. Distribution of six synaptic membrane antigens in subcellular fractions of rat brain cortex. Journal of Neurochemistry. 36: 1675-82. PMID 7241127  0.6
1980 Mahadik SP, Korenovsky A, Huang YY, Graf L, Rapport MM. Synaptic membrane antigens: detection and characterization. Journal of Neuroscience Methods. 2: 169-82. PMID 7392670 DOI: 10.1016/0165-0270(80)90058-8  0.6
1980 Rapport MM, Karpiak SE, Mahadik SP. Perturbation of CNS functions by antibodies to gangliosides. Speculations on biological roles of ganglioside receptors. Advances in Experimental Medicine and Biology. 125: 335-8. PMID 6244723  0.6
1979 Mahadik SP, Korenovsky A, Rapport MM. Heterogeneity of S-100 proteins of brain: subunit compositions. Journal of Neurochemistry. 33: 751-62. PMID 479890  0.6
1979 Rapport MM, Karpiak SE, Mahadik SP. Biological activities of antibodies injected into the brain. Federation Proceedings. 38: 2391-6. PMID 478015  0.6
1979 Mahadik SP, Graf L, Korenovsky A, Rapport MM. Immunochemical properties of S-100 proteins and their subunits. Journal of Neurochemistry. 33: 763-71. PMID 90122  0.6
1978 Karpiak SE, Mahadik SP, Rapport MM. Ganglioside receptors and induction of epileptiform activity: cholera toxin and choleragenoid (B subunits). Experimental Neurology. 62: 256-9. PMID 729673 DOI: 10.1016/0014-4886(78)90055-9  0.6
1978 Mahadik SP, Hungund B, Rapport MM. Topographic studies of glycoproteins of intact synaptosomes from rat brain cortex. Biochimica Et Biophysica Acta. 511: 240-50. PMID 678543 DOI: 10.1016/0005-2736(78)90317-6  0.6
1978 Laev H, Rapport MM, Mahadik SP, Silverman AJ. Immunohistological localization of ganglioside in rat cerebellum. Brain Research. 157: 136-41. PMID 359105 DOI: 10.1016/0006-8993(78)91002-8  0.6
1976 Tamir H, Mahadik SP, Rapport MM. Fractionation of synaptic membranes with sodium diatrizoate. Analytical Biochemistry. 76: 634-47. PMID 998996 DOI: 10.1016/0003-2697(76)90356-0  0.6
1976 Mahadik SP, Korenovsky A, Rapport MM. Slab gel analysis of the polypeptide components of rat brain subcellular organelles. Analytical Biochemistry. 76: 615-33. PMID 998995 DOI: 10.1016/0003-2697(76)90355-9  0.6
1976 Mahadik SP, Graf L, Rapport MM. Immunochemical studies of the interaction between myelin basic protein and S-100 protein. Journal of Neurochemistry. 27: 405-8. PMID 965983  0.6
1976 Perumal AS, Mahadik SP, Rapport MM. Mechanism of interaction of myelin basic protein and S-100 protein: metal binding and fluorescence studies. Journal of Neurochemistry. 27: 173-7. PMID 60466  0.6
1974 Mahadik SP, Dharmgrongartama B, Srinivasan PR. Regulation of host ribonucleic acid synthesis in bacteriophage T3-infected cells. Properties of an inhibitory protein of Escherichia coli ribonucleic acid polymerase. The Journal of Biological Chemistry. 249: 1787-91. PMID 4594239  0.6
1973 Dharmgrongartama B, Mahadik SP, Srinivasan PR. Modification of RNA polymerase after T3 phage infection of Escherichia coli B. Proceedings of the National Academy of Sciences of the United States of America. 70: 2845-9. PMID 4126728  0.6
1972 Mahadik SP, Dharmgrongartama B, Srinivasan PR. An inhibitory protein of Escherichia coli RNA polymerase in bacteriophage T3-infected cells (core polymerase-sigma factor-host polymerase-phage polymerase-initiation). Proceedings of the National Academy of Sciences of the United States of America. 69: 162-6. PMID 4550502  0.6
1971 Mahadik SP, Srinivasan PR. Stimulation of DNA-dependent RNA synthesis by a protein associated with ribosomes. Proceedings of the National Academy of Sciences of the United States of America. 68: 1898-901. PMID 4331564  0.6
1968 Mahadik SP, SivaRaman C. Citrate lyase: molecular weight and subunit structure. Biochemical and Biophysical Research Communications. 32: 167-72. PMID 5672133  0.6
Show low-probability matches.